POLYPEPTIDES INHIBANT LE LIGAND CD40L

POLYPEPTIDES INHIBANT LE LIGAND CD40L

The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HSU, Jonathan, SOMPEL, Ariella Van de, VLACH, Jaromir, DEWILDE, Maarten, PATTYN, Els, BUYSE, Marie-Ange, MEERTS, Peter, BESTE, Gerald
Format: Patent
Sprache:fre
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HSU, Jonathan
SOMPEL, Ariella Van de
VLACH, Jaromir
DEWILDE, Maarten
PATTYN, Els
BUYSE, Marie-Ange
MEERTS, Peter
BESTE, Gerald
description The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of CD40L and are safe.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MA43302A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MA43302A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MA43302A3</originalsourceid><addsrcrecordid>eNrjZFAN8PeJDHANCPF0cQ1W8PTz8HRy9AtR8HFV8PF0d_RzUXB2MTHw4WFgTUvMKU7lhdLcDLJuriHOHrqpBfnxqcUFicmpeakl8b6OJsbGBkaOxoTkAX7cITw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>POLYPEPTIDES INHIBANT LE LIGAND CD40L</title><source>esp@cenet</source><creator>HSU, Jonathan ; SOMPEL, Ariella Van de ; VLACH, Jaromir ; DEWILDE, Maarten ; PATTYN, Els ; BUYSE, Marie-Ange ; MEERTS, Peter ; BESTE, Gerald</creator><creatorcontrib>HSU, Jonathan ; SOMPEL, Ariella Van de ; VLACH, Jaromir ; DEWILDE, Maarten ; PATTYN, Els ; BUYSE, Marie-Ange ; MEERTS, Peter ; BESTE, Gerald</creatorcontrib><description>The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of CD40L and are safe.</description><language>fre</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210317&amp;DB=EPODOC&amp;CC=MA&amp;NR=43302A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210317&amp;DB=EPODOC&amp;CC=MA&amp;NR=43302A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HSU, Jonathan</creatorcontrib><creatorcontrib>SOMPEL, Ariella Van de</creatorcontrib><creatorcontrib>VLACH, Jaromir</creatorcontrib><creatorcontrib>DEWILDE, Maarten</creatorcontrib><creatorcontrib>PATTYN, Els</creatorcontrib><creatorcontrib>BUYSE, Marie-Ange</creatorcontrib><creatorcontrib>MEERTS, Peter</creatorcontrib><creatorcontrib>BESTE, Gerald</creatorcontrib><title>POLYPEPTIDES INHIBANT LE LIGAND CD40L</title><description>The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of CD40L and are safe.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAN8PeJDHANCPF0cQ1W8PTz8HRy9AtR8HFV8PF0d_RzUXB2MTHw4WFgTUvMKU7lhdLcDLJuriHOHrqpBfnxqcUFicmpeakl8b6OJsbGBkaOxoTkAX7cITw</recordid><startdate>20210317</startdate><enddate>20210317</enddate><creator>HSU, Jonathan</creator><creator>SOMPEL, Ariella Van de</creator><creator>VLACH, Jaromir</creator><creator>DEWILDE, Maarten</creator><creator>PATTYN, Els</creator><creator>BUYSE, Marie-Ange</creator><creator>MEERTS, Peter</creator><creator>BESTE, Gerald</creator><scope>EVB</scope></search><sort><creationdate>20210317</creationdate><title>POLYPEPTIDES INHIBANT LE LIGAND CD40L</title><author>HSU, Jonathan ; SOMPEL, Ariella Van de ; VLACH, Jaromir ; DEWILDE, Maarten ; PATTYN, Els ; BUYSE, Marie-Ange ; MEERTS, Peter ; BESTE, Gerald</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MA43302A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>HSU, Jonathan</creatorcontrib><creatorcontrib>SOMPEL, Ariella Van de</creatorcontrib><creatorcontrib>VLACH, Jaromir</creatorcontrib><creatorcontrib>DEWILDE, Maarten</creatorcontrib><creatorcontrib>PATTYN, Els</creatorcontrib><creatorcontrib>BUYSE, Marie-Ange</creatorcontrib><creatorcontrib>MEERTS, Peter</creatorcontrib><creatorcontrib>BESTE, Gerald</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HSU, Jonathan</au><au>SOMPEL, Ariella Van de</au><au>VLACH, Jaromir</au><au>DEWILDE, Maarten</au><au>PATTYN, Els</au><au>BUYSE, Marie-Ange</au><au>MEERTS, Peter</au><au>BESTE, Gerald</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>POLYPEPTIDES INHIBANT LE LIGAND CD40L</title><date>2021-03-17</date><risdate>2021</risdate><abstract>The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of CD40L and are safe.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language fre
recordid cdi_epo_espacenet_MA43302A
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title POLYPEPTIDES INHIBANT LE LIGAND CD40L
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T01%3A48%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HSU,%20Jonathan&rft.date=2021-03-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMA43302A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true